Glycogen Synthase Kinase-3 (GSK-3) is a pivotal enzyme involved in a multitude of cellular pathways, making it a significant target for therapeutic intervention. Inhibiting GSK-3 activity has shown promise in treating a wide array of conditions, and compounds like LY2090314 are at the forefront of this research. As a potent GSK-3 inhibitor, LY2090314 (CAS 603288-22-8) offers researchers valuable tools for exploring disease mechanisms and developing novel treatments.

The research applications of LY2090314 are diverse and expanding. Its ability to modulate key cellular processes such as cell proliferation, survival, and differentiation makes it relevant to various disease areas. For instance, studies have indicated that LY2090314 can promote the differentiation of intestinal progenitor cells, suggesting potential therapeutic benefits in inflammatory bowel diseases or regenerative medicine. This capacity to influence cell fate and function is a critical aspect for researchers investigating complex biological systems.

Furthermore, LY2090314's role as a GSK-3 inhibitor is of particular interest in oncology research. Aberrant GSK-3 activity is linked to uncontrolled cell growth and resistance to apoptosis in many cancer types. By inhibiting GSK-3, LY2090314 can potentially suppress tumor progression and enhance the effectiveness of other cancer therapies. Researchers looking to investigate these mechanisms can buy LY2090314 from reputable chemical suppliers who offer high-purity grades suitable for in vitro and in vivo studies.

For those involved in drug discovery and development, sourcing LY2090314 requires engaging with reliable manufacturers and suppliers. Companies often seek to obtain competitive price quotes and ensure the availability of the compound in the quantities needed for their research. Partnering with a chemical provider that offers detailed product specifications, such as a purity of 97% min, and potentially free samples, is crucial for validating product quality and suitability for specific research protocols. The accessibility of such compounds from manufacturers in China has greatly facilitated global research efforts.

In summary, LY2090314 represents a significant tool for scientific exploration into GSK-3-related pathologies. Its dual role as a research inhibitor and an API intermediate underscores its importance in the pharmaceutical landscape. Researchers and developers seeking to leverage the power of GSK-3 inhibition can rely on the availability of high-quality LY2090314 from dedicated chemical suppliers.